Tags

Type your tag names separated by a space and hit enter

Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial.
Am J Clin Nutr 2010; 91(4):923-31AJ

Abstract

BACKGROUND

Dietary recommendations for selenium differ between countries, mainly because of uncertainties over the definition of optimal selenium status.

OBJECTIVE

The objective was to examine the dose-response relations for different forms of selenium.

DESIGN

A randomized, double-blind, placebo-controlled dietary intervention was carried out in 119 healthy men and women aged 50-64 y living in the United Kingdom. Daily placebo or selenium-enriched yeast tablets containing 50, 100, or 200 microg Se (approximately 60% selenomethionine), selenium-enriched onion meals (approximately 66% gamma-glutamyl-methylselenocysteine, providing the equivalent of 50 microg Se/d), or unenriched onion meals were consumed for 12 wk. Changes in platelet glutathione peroxidase activity and in plasma selenium and selenoprotein P concentrations were measured.

RESULTS

The mean baseline plasma selenium concentration for all subjects was 95.7 +/- 11.5 ng/mL, which increased significantly by 10 wk to steady state concentrations of 118.3 +/- 13.1, 152.0 +/- 24.3, and 177.4 +/- 26.3 ng/mL in those who consumed 50, 100, or 200 microg Se-yeast/d, respectively. Platelet glutathione peroxidase activity did not change significantly in response to either dose or form of selenium. Selenoprotein P increased significantly in all selenium intervention groups from an overall baseline mean of 4.99 +/- 0.80 microg/mL to 6.17 +/- 0.85, 6.73 +/- 1.01, 6.59 +/- 0.64, and 5.72 +/- 0.75 microg/mL in those who consumed 50, 100, or 200 microg Se-yeast/d and 50 microg Se-enriched onions/d, respectively.

CONCLUSIONS

Plasma selenoprotein P is a useful biomarker of status in populations with relatively low selenium intakes because it responds to different dietary forms of selenium. To optimize the plasma selenoprotein P concentration in this study, 50 microg Se/d was required in addition to the habitual intake of approximately 55 microg/d. In the context of established relations between plasma selenium and risk of cancer and mortality, and recognizing the important functions of selenoprotein P, these results provide important evidence for deriving estimated average requirements for selenium in adults. This trial was registered at clinicaltrials.gov as NCT00279812.

Authors+Show Affiliations

School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK. r.hurst1@uea.ac.ukNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20181815

Citation

Hurst, Rachel, et al. "Establishing Optimal Selenium Status: Results of a Randomized, Double-blind, Placebo-controlled Trial." The American Journal of Clinical Nutrition, vol. 91, no. 4, 2010, pp. 923-31.
Hurst R, Armah CN, Dainty JR, et al. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010;91(4):923-31.
Hurst, R., Armah, C. N., Dainty, J. R., Hart, D. J., Teucher, B., Goldson, A. J., ... Fairweather-Tait, S. J. (2010). Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. The American Journal of Clinical Nutrition, 91(4), pp. 923-31. doi:10.3945/ajcn.2009.28169.
Hurst R, et al. Establishing Optimal Selenium Status: Results of a Randomized, Double-blind, Placebo-controlled Trial. Am J Clin Nutr. 2010;91(4):923-31. PubMed PMID: 20181815.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. AU - Hurst,Rachel, AU - Armah,Charlotte N, AU - Dainty,Jack R, AU - Hart,Dave J, AU - Teucher,Birgit, AU - Goldson,Andrew J, AU - Broadley,Martin R, AU - Motley,Amy K, AU - Fairweather-Tait,Susan J, Y1 - 2010/02/24/ PY - 2010/2/26/entrez PY - 2010/2/26/pubmed PY - 2010/4/8/medline SP - 923 EP - 31 JF - The American journal of clinical nutrition JO - Am. J. Clin. Nutr. VL - 91 IS - 4 N2 - BACKGROUND: Dietary recommendations for selenium differ between countries, mainly because of uncertainties over the definition of optimal selenium status. OBJECTIVE: The objective was to examine the dose-response relations for different forms of selenium. DESIGN: A randomized, double-blind, placebo-controlled dietary intervention was carried out in 119 healthy men and women aged 50-64 y living in the United Kingdom. Daily placebo or selenium-enriched yeast tablets containing 50, 100, or 200 microg Se (approximately 60% selenomethionine), selenium-enriched onion meals (approximately 66% gamma-glutamyl-methylselenocysteine, providing the equivalent of 50 microg Se/d), or unenriched onion meals were consumed for 12 wk. Changes in platelet glutathione peroxidase activity and in plasma selenium and selenoprotein P concentrations were measured. RESULTS: The mean baseline plasma selenium concentration for all subjects was 95.7 +/- 11.5 ng/mL, which increased significantly by 10 wk to steady state concentrations of 118.3 +/- 13.1, 152.0 +/- 24.3, and 177.4 +/- 26.3 ng/mL in those who consumed 50, 100, or 200 microg Se-yeast/d, respectively. Platelet glutathione peroxidase activity did not change significantly in response to either dose or form of selenium. Selenoprotein P increased significantly in all selenium intervention groups from an overall baseline mean of 4.99 +/- 0.80 microg/mL to 6.17 +/- 0.85, 6.73 +/- 1.01, 6.59 +/- 0.64, and 5.72 +/- 0.75 microg/mL in those who consumed 50, 100, or 200 microg Se-yeast/d and 50 microg Se-enriched onions/d, respectively. CONCLUSIONS: Plasma selenoprotein P is a useful biomarker of status in populations with relatively low selenium intakes because it responds to different dietary forms of selenium. To optimize the plasma selenoprotein P concentration in this study, 50 microg Se/d was required in addition to the habitual intake of approximately 55 microg/d. In the context of established relations between plasma selenium and risk of cancer and mortality, and recognizing the important functions of selenoprotein P, these results provide important evidence for deriving estimated average requirements for selenium in adults. This trial was registered at clinicaltrials.gov as NCT00279812. SN - 1938-3207 UR - https://www.unboundmedicine.com/medline/citation/20181815/Establishing_optimal_selenium_status:_results_of_a_randomized_double_blind_placebo_controlled_trial_ L2 - https://academic.oup.com/ajcn/article-lookup/doi/10.3945/ajcn.2009.28169 DB - PRIME DP - Unbound Medicine ER -